Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000663191 | SCV000786364 | likely benign | Paragangliomas 5 | 2018-04-17 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002060801 | SCV002410563 | benign | Mitochondrial complex II deficiency, nuclear type 1; Paragangliomas 5 | 2025-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004017712 | SCV004849286 | likely benign | Hereditary cancer-predisposing syndrome | 2015-08-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |